JAMES GROCE: Open Payments
NPI 1811090566 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 55 payments from 9 companies in 2025. Trend: 2023 $927 · 2024 $477 · 2025 $1,081
Food & beverage: $1,069Education: $11
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 7 | $213 |
| Janssen Pharmaceuticals, Inc | 8 | $161 |
| Alkermes, Inc. | 11 | $152 |
| E.R. Squibb & Sons, L.L.C. | 7 | $144 |
| ABBVIE INC. | 10 | $138 |
| Vanda Pharmaceuticals Inc. | 5 | $134 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
Products named: SUBLOCADE, INVEGA SUSTENNA, COBENFY, VRAYLAR, HETLIOZ, ARISTADA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
